Index by author

October 01, 2005; Volume 32,Issue 10

A

  1. Ainola, Mari

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  2. Akikusa, Jonathan D

    1. Eye findings in patients with juvenile dermatomyositis.
      Jonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin and Brian M Feldman
      The Journal of Rheumatology October 1 2005, 32 (10) 1986-1991;

  3. Aletaha, Daniel

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  4. Alexopoulou, Alexandra

    1. Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
      Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis
      The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;

  5. Alvarez-Nemegyei, José

    1. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
      José Alvarez-Nemegyei, Julio Cesar Cen-Pisté, Martha Medina-Escobedo and Salha Villanueva-Jorge
      The Journal of Rheumatology October 1 2005, 32 (10) 1923-1927;

  6. Anderson, Jennifer J

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  7. Andriamanalijaona, Rina

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  8. Apalset, Ellen M

    1. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
      Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun
      The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;

  9. Archimandritis, Athanasios J

    1. Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
      Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis
      The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;

  10. Arokoski, Jari P A

    1. Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
      Lorenzo Sandini, Jari P A Arokoski, Jukka S Jurvelin and Heikki Kröger
      The Journal of Rheumatology October 1 2005, 32 (10) 1951-1957;

B

  1. Baraliakos, Xenophon

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  2. Bartsch, Jörg Walter

    1. ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
      Silvia Naus and Jörg Walter Bartsch
      The Journal of Rheumatology October 1 2005, 32 (10) 1870-1872;

  3. Baugé, Catherine

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  4. Bell, Mary

    1. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
      David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel
      The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;

  5. Boers, Maarten

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  6. Bombardier, Claire

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  7. Boumediene, Karim

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  8. Braun, JÜrgen

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  9. Braun, Jürgen

    1. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
    2. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
      Kay-Geert A Hermann, Robert B M Landewé, Jürgen Braun and Désirée M F M van der Heijde
      The Journal of Rheumatology October 1 2005, 32 (10) 2056-2060;

  10. Brooks, Peter M

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    3. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  11. Brun, Johan G

    1. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
      Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun
      The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;

C

  1. Caldwell, Jacques

    1. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
      David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel
      The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;

  2. Caplan, Liron

    1. Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
      Liron Caplan, Anthony S Russell and Frederick Wolfe
      The Journal of Rheumatology October 1 2005, 32 (10) 1863-1865;

  3. Carlton, Kerri

    1. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;
    2. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  4. Cen-Pisté, Julio Cesar

    1. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
      José Alvarez-Nemegyei, Julio Cesar Cen-Pisté, Martha Medina-Escobedo and Salha Villanueva-Jorge
      The Journal of Rheumatology October 1 2005, 32 (10) 1923-1927;

  5. Chambers, Sharon

    1. Malignancy and rheumatic disease--a real association?
      Sharon Chambers and David Isenberg
      The Journal of Rheumatology October 1 2005, 32 (10) 1866-1867;

  6. Chen, Tong

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  7. Choi, Hyon K

    1. Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
      Frederick Wolfe, Kaleb Michaud, Hyon K Choi and Rhys Williams
      The Journal of Rheumatology October 1 2005, 32 (10) 1875-1883;

  8. Cicuttini, Flavia

    1. The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
      Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
      The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;

  9. Cinelli, Marina

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

  10. Clauw, Daniel J

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  11. Cooley, Helen

    1. The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
      Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
      The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;

  12. Cuttner, Janet

    1. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
      Janet Cuttner, Harry Spiera, Kevin Troy and Sylvan Wallenstein
      The Journal of Rheumatology October 1 2005, 32 (10) 1884-1887;

D

  1. Dagfinrud, Hanne

    1. The Cochrane review of physiotherapy interventions for ankylosing spondylitis.
      Hanne Dagfinrud, Tore K Kvien and Kåre B Hagen
      The Journal of Rheumatology October 1 2005, 32 (10) 1899-1906;

  2. Davis, John C

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

  3. Davis, John M

    1. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
      John M Davis 3rd, Hilal Maradit-Kremers and Sherine E Gabriel
      The Journal of Rheumatology October 1 2005, 32 (10) 1856-1862;

  4. Day, Richard O

    1. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    2. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  5. de Wit, Marten

    1. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  6. Ding, Changhai

    1. The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
      Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
      The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;

  7. Distler, Oliver

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

  8. Dougados, Maxime

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
      Florence Tubach, George A Wells, Philippe Ravaud and Maxime Dougados
      The Journal of Rheumatology October 1 2005, 32 (10) 2025-2029;

  9. Dourakis, Spyros P

    1. Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
      Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis
      The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;

  10. Du, Ying

    1. Synovial sarcoma of the foot mimicking acute gouty arthritis.
      Ying Du, Sally Pullman-Mooar and H Ralph Schumacher
      The Journal of Rheumatology October 1 2005, 32 (10) 2006-2008;

E

  1. Edmonds, John P

    1. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;

  2. Edwards, I Ralph

    1. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  3. Emery, Paul

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  4. Etchells, Edward

    1. Preventing deaths from methotrexate overdose.
      Edward Etchells
      The Journal of Rheumatology October 1 2005, 32 (10) 1853-1855;

  5. Ettinger, Mark P

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

F

  1. Falappone, Paola Chiara Francesca

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

  2. Feldman, Brian M

    1. Eye findings in patients with juvenile dermatomyositis.
      Jonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin and Brian M Feldman
      The Journal of Rheumatology October 1 2005, 32 (10) 1986-1991;

  3. Felsenberg, Dieter

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  4. Felson, David T

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  5. Fransen, Jaap

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  6. Fries, James F

    1. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    2. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  7. Furst, Dan E

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  8. Furst, Daniel E

    1. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    2. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

G

  1. Gabriel, Sherine E

    1. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
      John M Davis 3rd, Hilal Maradit-Kremers and Sherine E Gabriel
      The Journal of Rheumatology October 1 2005, 32 (10) 1856-1862;

  2. Gatto, Hugues

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  3. Gendreau, Judy F

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  4. Gendreau, R Michael

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  5. Gimbel, Joseph

    1. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
      David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel
      The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;

  6. Gracely, Richard H

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  7. Guiducci, Serena

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

H

  1. Hagen, Kåre B

    1. The Cochrane review of physiotherapy interventions for ankylosing spondylitis.
      Hanne Dagfinrud, Tore K Kvien and Kåre B Hagen
      The Journal of Rheumatology October 1 2005, 32 (10) 1899-1906;

  2. Hallett, Dave

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  3. Harris, Steven T

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  4. Hazes, Johanna M W

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  5. Hermann, Kay-Geert A

    1. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
    2. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;
    3. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
      Kay-Geert A Hermann, Robert B M Landewé, Jürgen Braun and Désirée M F M van der Heijde
      The Journal of Rheumatology October 1 2005, 32 (10) 2056-2060;

  6. Hiebert, Lori

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

  7. Hiltbrunner, Valerie

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

I

  1. Iannone, Florenzo

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

  2. Inman, Robert D

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  3. Ionescu, Mirela

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

  4. Isenberg, David

    1. Malignancy and rheumatic disease--a real association?
      Sharon Chambers and David Isenberg
      The Journal of Rheumatology October 1 2005, 32 (10) 1866-1867;

J

  1. Johannessen, Arild E

    1. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
      Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun
      The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;

  2. Johnson, Kent R

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    3. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;
    4. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  3. Jones, Graeme

    1. The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
      Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
      The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;

  4. Juan, Antonio

    1. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
      Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros
      The Journal of Rheumatology October 1 2005, 32 (10) 2061;

  5. Jurik, Anne-Grethe

    1. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
    2. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  6. Jurvelin, Jukka S

    1. Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
      Lorenzo Sandini, Jari P A Arokoski, Jukka S Jurvelin and Heikki Kröger
      The Journal of Rheumatology October 1 2005, 32 (10) 1951-1957;

K

  1. Keil, Wolfgang

    1. Deaths following methotrexate overdoses by medical staff.
      Inga Sinicina, Barbara Mayr, Gita Mall and Wolfgang Keil
      The Journal of Rheumatology October 1 2005, 32 (10) 2009-2011;

  2. Kim, Tae-Hwan

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  3. King, Lindsay

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

  4. Kirwan, John R

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    3. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;
    4. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  5. Konttinen, Yrjö T

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  6. Kranzler, Jay D

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  7. Kröger, Heikki

    1. Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
      Lorenzo Sandini, Jari P A Arokoski, Jukka S Jurvelin and Heikki Kröger
      The Journal of Rheumatology October 1 2005, 32 (10) 1951-1957;

  8. Kuwata, Shoji

    1. CTLA-4 -1661A/G and -1772T/C dimorphisms in Japanese patients with systemic lupus erythematosus.
      Fujio Takeuchi, Shoji Kuwata and Masaki Mori
      The Journal of Rheumatology October 1 2005, 32 (10) 2062;

  9. Kvien, Tore K

    1. The Cochrane review of physiotherapy interventions for ankylosing spondylitis.
      Hanne Dagfinrud, Tore K Kvien and Kåre B Hagen
      The Journal of Rheumatology October 1 2005, 32 (10) 1899-1906;

  10. Kypriotou, Madeleine

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

L

  1. Lambert, Robert G

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  2. Landewé, Robert

    1. Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT.
      Désirée van der Heijde and Robert Landewé
      The Journal of Rheumatology October 1 2005, 32 (10) 2048-2049;

  3. Landewé, Robert B M

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
    3. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
      Kay-Geert A Hermann, Robert B M Landewé, Jürgen Braun and Désirée M F M van der Heijde
      The Journal of Rheumatology October 1 2005, 32 (10) 2056-2060;

  4. LandewÉ, Robert B M

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  5. Lapadula, Giovanni

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

  6. Lassere, Marissa N D

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    3. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;
    4. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

  7. Legendre, Florence

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  8. Levin, Alex V

    1. Eye findings in patients with juvenile dermatomyositis.
      Jonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin and Brian M Feldman
      The Journal of Rheumatology October 1 2005, 32 (10) 1986-1991;

  9. Liljeström, Mikko

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  10. Lobanok, Tatiana

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

M

  1. Ma, Guofeng

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  2. Madland, Tor Magne

    1. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
      Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun
      The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;

  3. Maksymowych, Walter P

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;
    2. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;

  4. Mall, Gita

    1. Deaths following methotrexate overdoses by medical staff.
      Inga Sinicina, Barbara Mayr, Gita Mall and Wolfgang Keil
      The Journal of Rheumatology October 1 2005, 32 (10) 2009-2011;

  5. Maradit-Kremers, Hilal

    1. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
      John M Davis 3rd, Hilal Maradit-Kremers and Sherine E Gabriel
      The Journal of Rheumatology October 1 2005, 32 (10) 1856-1862;

  6. Matucci-Cerinic, Marco

    1. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
      Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
      The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;

  7. Mayes, Maureen D

    1. Race, scleroderma, and survival: why is there a difference?
      Maureen D Mayes
      The Journal of Rheumatology October 1 2005, 32 (10) 1873-1874;

  8. Mayr, Barbara

    1. Deaths following methotrexate overdoses by medical staff.
      Inga Sinicina, Barbara Mayr, Gita Mall and Wolfgang Keil
      The Journal of Rheumatology October 1 2005, 32 (10) 2009-2011;

  9. McDonald Blumer, M Heather

    1. Bone mineral content versus bone density in a population with osteoarthritis: a new twist to the controversy?
      M Heather McDonald Blumer
      The Journal of Rheumatology October 1 2005, 32 (10) 1868-1869;

  10. McLean, Samuel A

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  11. Mease, Philip J

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  12. Medina-Escobedo, Martha

    1. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
      José Alvarez-Nemegyei, Julio Cesar Cen-Pisté, Martha Medina-Escobedo and Salha Villanueva-Jorge
      The Journal of Rheumatology October 1 2005, 32 (10) 1923-1927;

  13. Michael, Rachel

    1. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;

  14. Michaud, Kaleb

    1. Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
      Frederick Wolfe, Kaleb Michaud, Hyon K Choi and Rhys Williams
      The Journal of Rheumatology October 1 2005, 32 (10) 1875-1883;
    2. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  15. Miller, Paul D

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  16. Mitchell, Holly C

    1. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
      Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley
      The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;

  17. Monginoux, Patricia

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  18. Mori, Masaki

    1. CTLA-4 -1661A/G and -1772T/C dimorphisms in Japanese patients with systemic lupus erythematosus.
      Fujio Takeuchi, Shoji Kuwata and Masaki Mori
      The Journal of Rheumatology October 1 2005, 32 (10) 2062;

N

  1. Nadal, Cristina

    1. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
      Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros
      The Journal of Rheumatology October 1 2005, 32 (10) 2061;

  2. Naus, Silvia

    1. ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
      Silvia Naus and Jörg Walter Bartsch
      The Journal of Rheumatology October 1 2005, 32 (10) 1870-1872;

  3. Neustadt, David

    1. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
      David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel
      The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;

  4. Nietert, Paul J

    1. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
      Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley
      The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;

O

  1. O'Connor, Philip J

    1. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;

  2. Østergaard, Mikkel

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

P

  1. Park, Yong-Wook

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  2. Payne, Ursula

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  3. Poduval, Praseet

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  4. Poole, A Robin

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

  5. Pujol, Jean-Pierre

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  6. Pullman-Mooar, Sally

    1. Synovial sarcoma of the foot mimicking acute gouty arthritis.
      Ying Du, Sally Pullman-Mooar and H Ralph Schumacher
      The Journal of Rheumatology October 1 2005, 32 (10) 2006-2008;

R

  1. Rahman, Proton

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  2. Raoudi, Maha

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  3. Rappo, Joy

    1. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;

  4. Ravaud, Philippe

    1. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
      Florence Tubach, George A Wells, Philippe Ravaud and Maxime Dougados
      The Journal of Rheumatology October 1 2005, 32 (10) 2025-2029;

  5. Renard, Emmanuelle

    1. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
      Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
      The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;

  6. Ribas, Bartolome

    1. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
      Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros
      The Journal of Rheumatology October 1 2005, 32 (10) 2061;

  7. Ribeiro, Saulo

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  8. Ros, Imnaculada

    1. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
      Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros
      The Journal of Rheumatology October 1 2005, 32 (10) 2061;

  9. Rosenberg, Alan M

    1. Longitudinal analysis of a pediatric rheumatology clinic population.
      Alan M Rosenberg
      The Journal of Rheumatology October 1 2005, 32 (10) 1992-2001;

  10. Rossebö, Berthe

    1. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
      Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun
      The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;

  11. Rudwaleit, Martin

    1. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
    2. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  12. Russell, Anthony S

    1. Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
      Liron Caplan, Anthony S Russell and Frederick Wolfe
      The Journal of Rheumatology October 1 2005, 32 (10) 1863-1865;

S

  1. Salonen, David C

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  2. Sandini, Lorenzo

    1. Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
      Lorenzo Sandini, Jari P A Arokoski, Jukka S Jurvelin and Heikki Kröger
      The Journal of Rheumatology October 1 2005, 32 (10) 1951-1957;

  3. Santavirta, Seppo

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;

  4. Schimmer, Ralph C

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  5. Schumacher, H Ralph

    1. Synovial sarcoma of the foot mimicking acute gouty arthritis.
      Ying Du, Sally Pullman-Mooar and H Ralph Schumacher
      The Journal of Rheumatology October 1 2005, 32 (10) 2006-2008;

  6. Scott, Fiona

    1. The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
      Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
      The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;

  7. Shaftman, Stephanie R

    1. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
      Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley
      The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;

  8. Shea, Beverley

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  9. Silman, Alan J

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  10. Silver, Richard M

    1. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
      Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley
      The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;

  11. Simon, Lee S

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  12. Sinicina, Inga

    1. Deaths following methotrexate overdoses by medical staff.
      Inga Sinicina, Barbara Mayr, Gita Mall and Wolfgang Keil
      The Journal of Rheumatology October 1 2005, 32 (10) 2009-2011;

  13. Skag, Arne

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  14. Smolen, Josef S

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  15. Spiera, Harry

    1. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
      Janet Cuttner, Harry Spiera, Kevin Troy and Sylvan Wallenstein
      The Journal of Rheumatology October 1 2005, 32 (10) 1884-1887;

  16. Stamoulis, Nikolaos D

    1. Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
      Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis
      The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;

  17. Stankovich, James

    1. The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
      Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
      The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;

  18. Stone, Millicent A

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

  19. Strand, C Vibeke

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  20. Suarez-Almazor, Maria

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

T

  1. Takeuchi, Fujio

    1. CTLA-4 -1661A/G and -1772T/C dimorphisms in Japanese patients with systemic lupus erythematosus.
      Fujio Takeuchi, Shoji Kuwata and Masaki Mori
      The Journal of Rheumatology October 1 2005, 32 (10) 2062;

  2. Tennankore, Dhenuka K

    1. Eye findings in patients with juvenile dermatomyositis.
      Jonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin and Brian M Feldman
      The Journal of Rheumatology October 1 2005, 32 (10) 1986-1991;

  3. Thorn, Michael D

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  4. Tilley, Barbara C

    1. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
      Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley
      The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;

  5. Troy, Kevin

    1. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
      Janet Cuttner, Harry Spiera, Kevin Troy and Sylvan Wallenstein
      The Journal of Rheumatology October 1 2005, 32 (10) 1884-1887;

  6. Tubach, Florence

    1. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
      Florence Tubach, George A Wells, Philippe Ravaud and Maxime Dougados
      The Journal of Rheumatology October 1 2005, 32 (10) 2025-2029;

  7. Tugwell, Peter S

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    3. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

V

  1. Van der Heijde, Desiree M F M

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  2. van der Heijde, DÉsirÉÉe M F M

    1. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
      Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;

  3. van der Heijde, Désirée

    1. Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT.
      Désirée van der Heijde and Robert Landewé
      The Journal of Rheumatology October 1 2005, 32 (10) 2048-2049;

  4. van der Heijde, Désirée M F M

    1. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
      Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
      The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
    2. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
      Kay-Geert A Hermann, Robert B M Landewé, Jürgen Braun and Désirée M F M van der Heijde
      The Journal of Rheumatology October 1 2005, 32 (10) 2056-2060;

  5. van Riel, Piet L C M

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  6. Van Santen, Susanne

    1. Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
      Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
      The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;

  7. Vassilopoulos, Dimitrios

    1. Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
      Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis
      The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;

  8. Villanueva-Jorge, Salha

    1. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
      José Alvarez-Nemegyei, Julio Cesar Cen-Pisté, Martha Medina-Escobedo and Salha Villanueva-Jorge
      The Journal of Rheumatology October 1 2005, 32 (10) 1923-1927;

W

  1. Wade, John

    1. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
      David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel
      The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;

  2. Wallenstein, Sylvan

    1. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
      Janet Cuttner, Harry Spiera, Kevin Troy and Sylvan Wallenstein
      The Journal of Rheumatology October 1 2005, 32 (10) 1884-1887;

  3. Wasnich, Richard

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  4. Webb, Alison

    1. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
      Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
      The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;

  5. Wells, George A

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
    2. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
      Florence Tubach, George A Wells, Philippe Ravaud and Maxime Dougados
      The Journal of Rheumatology October 1 2005, 32 (10) 2025-2029;

  6. Williams, David A

    1. Efficacy of milnacipran in patients with fibromyalgia.
      R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
      The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;

  7. Williams, Rhys

    1. Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
      Frederick Wolfe, Kaleb Michaud, Hyon K Choi and Rhys Williams
      The Journal of Rheumatology October 1 2005, 32 (10) 1875-1883;

  8. Wilson, Katie

    1. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
      Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
      The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;

  9. Wolfe, Fred

    1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
      George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
      The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;

  10. Wolfe, Frederick

    1. Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
      Liron Caplan, Anthony S Russell and Frederick Wolfe
      The Journal of Rheumatology October 1 2005, 32 (10) 1863-1865;
    2. Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
      Frederick Wolfe, Kaleb Michaud, Hyon K Choi and Rhys Williams
      The Journal of Rheumatology October 1 2005, 32 (10) 1875-1883;

  11. Woodworth, Thasia G

    1. Challenges and progress in adverse event ascertainment and reporting in clinical trials.
      Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
    2. Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
      Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
      The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;

Y

  1. Yoo, Dae-Hyun

    1. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
      Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
      The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;

Z

  1. Zhao, Desheng

    1. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
      Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
      The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;
Back to top

In this issue